In this review, we discuss the discovery and biologic significance of HE4 and evaluate available evidence regarding the utility of HE4 as a biomarker for ovarian and endometrial cancer.
Robert C. Bast, Jr, MD
Advertisement
Articles by Robert C. Bast, Jr, MD
Advertisement
Latest Updated Articles
The Emerging Role of HE4 in the Evaluation of Epithelial Ovarian and Endometrial CarcinomasPublished: June 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
2
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
3
Forming CUTNETs: A Joint Venture Between Surgery and Oncology in NETs
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
